Connetics Corporation Announces Special Meeting Of Stockholders To Approve Merger With Stiefel Laboratories

PALO ALTO, Calif.--(BUSINESS WIRE)--Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, today announced that it has scheduled a special stockholders’ meeting, to be held on Wednesday, December 20, 2006, at 9:00 a.m. Pacific Time, of its stockholders of record as of the close of business on November 13, 2006, to vote to approve its proposed merger with Stiefel Laboratories, Inc.